#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Toxic epidermal necrolysis Mucopolysaccharidosis III Squamous cell carcinoma of the cervix Advanced systemic mastocytosis Immunodeficiency congenital Ventricular fibrillation Allogenic stem cell transplantation Glomerulonephritis minimal lesion Dent's disease Li-Fraumeni syndrome Astrocytoma malignant Malignant neoplasm of choroid Extra-osseous Ewing's sarcoma metastatic Sarcoidosis Netherton's syndrome More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis KBG syndrome – Diagnostics Tuberous sclerosis complex Chondrosarcoma metastatic – Basic Information Pemphigus – Basic Information X-linked lymphoproliferative syndrome Leiomyosarcoma – Treatment Systemic mastocytosis – Basic Information Langerhans’ cell histiocytosis – Basic Information Rett syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    INOBRODIB Romiplostim Taurine Namilumab NALMEFENE HYDROCHLORIDE Lisaftoclax Apraglutide Cenerimod Redasemtide Lisinopril Cobamamide Intestifix Glucose Gallium (68Ga) Gozetotide Morphine Hydrochloride Ads-013 PRT3789 Isotretinoin D5-Ethyl-Beta-D-Glucuronide Aclidinium Bromide More therapies…

    Learn about Your Condition

    Thrombolysis Palmoplantar pustulosis Psychotic disorder Deafness bilateral Peritonitis Progressive multiple sclerosis Cardiac sarcoidosis Psoriatic arthropathy Gastrointestinal carcinoma Toxic epidermal necrolysis Hypomagnesaemia Tricuspid valve disease C3 glomerulopathy Multiple sclerosis relapse Rhabdoid tumour of the kidney More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pia Fondazione Di Culto E Religione Card G Panico

Pia Fondazione Di Culto E Religione Card G Panico

Via Pio X 4, Tricase, 73039, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of RO7269162 in people at risk for or with early-stage Alzheimer’s Disease: Effects on brain amyloid buildup

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Prodromal Alzheimer’s disease
    Investigated Drugs:
    • Florbetaben (18F)
    • Flutemetamol (18F)
    • Ro7269162
    Denmark France Germany Italy Poland Spain

  • Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epirubicin
    • Olaparib
    • Capecitabine
    Austria Belgium Bulgaria France Germany Hungary +3

  • Study on Encorafenib, Cetuximab, and FOLFIRI for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer After Progression on Encorafenib and Cetuximab

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    Investigated Drugs:
    • Irinotecan Hydrochloride
    • Cetuximab
    • Encorafenib
    Italy

  • Study of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tremelimumab
    • Durvalumab
    • Infliximab
    Belgium France Germany Italy Portugal Spain

  • Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • Mirodenafil Dihydrochloride
    Czechia Denmark France Germany Italy The Netherlands +2

  • Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Biliary neoplasm
    Investigated Drugs:
    • Glucose
    • Tegafur
    • Capecitabine
    Belgium Denmark France Germany Italy Norway +2

  • Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Cyclophosphamide
    • Doxorubicin
    Austria Belgium Czechia France Germany Italy +3

  • Study of ACP-204 for Treating Psychosis in Adults with Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy Spain

  • Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Disitamab Vedotin
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Greece Hungary +7

  • Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Savolitinib
    • Durvalumab
    • Infliximab
    Czechia France Germany Italy The Netherlands Poland +2
Previous Page
1 … 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!